Global Markets
Novo Nordisk (NOVOB DC) announces that the EU commission has approved more effective dose of injectable Wegovy for adults with obesity; study people lost about 21% of their body weight on average
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
